Management of Children and Adolescents with Wilson Disease and Neurological Worsening Following D–Penicillamine Therapy: A Single Centre Experience

BACKGROUND: Most centers in developing countries prefer chelation therapy with D-penicillamine for the management of Wilson's disease (WD) because of its easy availability and affordability. Neurological worsening following treatment with D-penicillamine is not uncommon. However, there is a pau...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Madhan, Murugan, T. P, Lionel, Arul P., Thomas, Maya M., Mannam, Pavithra, Yoganathan, Sangeetha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540946/
https://www.ncbi.nlm.nih.gov/pubmed/36211139
http://dx.doi.org/10.4103/aian.aian_519_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540946/
https://www.ncbi.nlm.nih.gov/pubmed/36211139
http://dx.doi.org/10.4103/aian.aian_519_21

Ejemplares similares